Maryland · 2026 Regular Session · Bill

HB 1426: Clinical Research Pharmacies and Clinical Trials - Permits and Ownership

Passed one chamber Last action April 13, 2026: Referred Rules

Plain-language summary

HB 1426 is a bill introduced in the Maryland House on February 13, 2026. According to its official title, it concerns: Clinical Research Pharmacies and Clinical Trials - Permits and Ownership. Primary sponsor: Jared Solomon (Democratic), Heather Bagnall Tudball (Democratic), Bonnie Cullison (Democratic), Pam Guzzone (Democratic), Terri Hill (Democratic), Tom Hutchinson (Republican), Steve Johnson (Democratic), Aaron Kaufman (Democratic), Nic Kipke (Republican), Lesley Lopez (Democratic), Martinez, Teresa Reilly (Republican), Sandy Rosenberg (Democratic), Kim Ross (Democratic), Deni Taveras (Democratic), Jennifer White Holland (Democratic), Teresa Woorman (Democratic). Most recent recorded action (April 13, 2026): Referred Rules.

Sponsors

Primary sponsors: Jared Solomon (Democratic); Heather Bagnall Tudball (Democratic); Bonnie Cullison (Democratic); Pam Guzzone (Democratic); and 13 more.